Rallybio Ratios (2022-2026) | RLYB

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -5,267.22%-3,621.74%-27,931.58%-4,175.47%-4,441.51%7,554.72%-2,636.04%-3,904.72%
EBIT Margin (Quarter) -5,697.32%-4,035.45%-30,547.37%-4,561.32%-4,743.87%-3,266.51%-2,888.29%-4,119.34%
EBITDA Margin (Quarter) -5,430.10%-3,754.52%-29,328.95%-4,462.26%-4,591.04%7,558.02%-2,638.74%-3,912.74%
Operating Margin (Quarter) -5,697.32%-4,035.45%-30,547.37%-4,561.32%-4,743.87%-3,266.51%-2,888.29%-4,119.34%
Net Margin (Quarter) -5,267.22%-3,621.74%-27,931.58%-4,175.47%-4,441.51%7,554.72%-2,636.04%-3,904.72%
FCF Margin (Quarter) -3,484.28%-4,530.10%-25,952.63%-4,813.68%-3,952.36%-3,089.62%-2,107.66%-3,763.21%
Efficiency
Assets Average (Quarter) 171.38M154.95M140.38M124.41M107.49M95.89M85.72M73.56M63.05M54.49M59.33M64.96M58.37M
Equity Average (Quarter) 162.26M147.23M131.42M114.88M97.67M84.59M75.42M66.24M57.86M50.02M54.50M60.49M54.12M
Invested Capital (Quarter) 169.32M155.20M139.26M123.58M106.18M89.16M80.02M70.82M61.65M54.07M45.96M63.03M57.96M50.28M
Asset Utilization Ratio (Quarter) 0.000.010.010.010.010.010.010.01
Leverage & Solvency
Equity Ratio (Quarter) 0.940.960.940.930.920.900.870.900.910.930.900.930.930.92
Valuation
Enterprise Value (Quarter) -168.99M-150.39M-137.84M-121.38M-109.93M-94.17M-88.61M-75.14M-65.51M-54.49M-45.75M-59.32M-54.74M-46.80M
Return Ratios
Return on Sales (Quarter) -0.53%-0.36%-2.79%-0.42%-0.44%0.76%-0.26%-0.39%
Return on Capital Employed (Quarter) -68.55%-82.49%-92.31%-90.29%-89.87%-85.19%-87.76%-69.80%-54.44%-59.25%
Return on Assets (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%